知搜-全球专利检索

  1. Login
  2. Sign Up

Search Results

45 records (took 0.016 seconds)

    PHARMACEUTICAL OR FOOD COMPOSITION COMPRISING OLDENLANDIA BRACHYPODA, SPERGULARIA MARINA, DISPORUM SMILACINUM, PERSICARIA POSUMBU, OR GEUM ALEPPICUM
    1.
    发明申请
    PHARMACEUTICAL OR FOOD COMPOSITION COMPRISING OLDENLANDIA BRACHYPODA, SPERGULARIA MARINA, DISPORUM SMILACINUM, PERSICARIA POSUMBU, OR GEUM ALEPPICUM 审中-公开
    包含OLDENLANDIA BRACHYPODA，SPERGULARIA MARINA，DISPORUM SMILACINUM，PERSICARIA POSUMBU或GEUM ALEPPICUM的药物或食品组合物

    公开(公告)号：US20150352167A1

    公开(公告)日：2015-12-10

    申请号：US14655703

    申请日：2013-11-12

    Applicant: KOREA FOOD RESEARCH INSTITUTE

    Inventor： Hye-Young KIM ,  Mee-Ra RHYU ,  Kyong KIM ,  Min PARK ,  Yu-Mi LEE

    IPC: A61K36/748 ,  A23L1/30 ,  A61K36/70 ,  A61K36/73 ,  A61K36/36 ,  A61K36/185

    CPC classification number: A61K36/185 ,  A23L33/105 ,  A23V2002/00 ,  A61K36/36 ,  A61K36/70 ,  A61K36/73 ,  A61K36/748 ,  A61K36/896 ,  A23V2200/322 ,  A23V2200/326 ,  A23V2200/328 ,  A23V2200/332 ,  A23V2250/21

    Abstract: The present disclosure relates to a pharmaceutical composition or a food composition which has excellent activity of stimulating enteroendocrine cells while being safe with few side effects. The composition contains one or more of an Oldenlandia brachypoda extract, a Spergularia marina extract, a Disporum smilacinum extract, a Persicaria posumbu extract and a Geum aleppicum extract as an active ingredient. The composition of the present disclosure can be usefully used as a pharmaceutical composition or a food composition for preventing, improving or treating diabetes mellitus, improving or treating heart diseases, improving or treating arteriosclerosis, improving or treating digestive disorders and malabsorption, preventing or treating obesity or suppressing appetite, protecting nerves, treating or improving liver diseases, and so forth. In addition, the composition of the present disclosure can promote the secretion of GLP-1, CCK or 5-HT, affect the activation of hTGR5 and act as TRP, TRPA1, G protein and PLCβ2 agonists.

    Abstract translation: 本公开内容涉及具有优异的刺激肠内分泌细胞的活性的药物组合物或食品组合物，同时安全且副作用少。 该组合物含有一种或多种龙胆oda oda提取物，精ia ina提取物，sm a提取物，Persicaria posumbu提取物和作为有效成分的绿草提取物中的一种或多种。 本公开的组合物可以有用地用作药物组合物或用于预防，改善或治疗糖尿病，改善或治疗心脏病，改善或治疗动脉硬化，改善或治疗消化系统疾病和吸收不良，预防或治疗肥胖症的食物组合物 或抑制食欲，保护神经，治疗或改善肝脏疾病等。 另外，本公开的组合物可促进GLP-1，CCK或5-HT的分泌，影响hTGR5的活化，并且作为TRP，TRPA1，G蛋白和PLC＆bgr2激动剂。

    Compositions and methods for treating hepatitis virus infection
    2.
    发明授权
    Compositions and methods for treating hepatitis virus infection 有权
    治疗肝炎病毒感染的组合物和方法

    公开(公告)号：US09028827B2

    公开(公告)日：2015-05-12

    申请号：US13197110

    申请日：2011-08-03

    Applicant: David C. P. Chen

    Inventor： David C. P. Chen

    IPC: A61K39/395 ,  A61K39/40 ,  A61K39/42 ,  C07K16/12 ,  A61K36/232 ,  A61K36/258 ,  A61K36/284 ,  A61K36/537 ,  A61K36/748 ,  A61K36/9066 ,  A61K36/9068 ,  A61K39/00

    CPC classification number: C07K16/121 ,  A61K35/57 ,  A61K36/232 ,  A61K36/258 ,  A61K36/284 ,  A61K36/537 ,  A61K36/748 ,  A61K36/9066 ,  A61K36/9068 ,  A61K39/40 ,  A61K2039/505 ,  C07K2317/11 ,  C07K2317/23 ,  A61K39/00 ,  A61K2300/00

    Abstract: The present invention relates to a method for treating hepatitis virus infection comprising administering to a subject infected with a hepatitis virus an effective amount of a yolk or yolk antibody obtained from an egg of a fowl which has been immunized using Helicobacter pylori as an antigen. In particular, the method is effective in reducing virus titer and/or decreasing a level of glutamic oxaloacetic transaminase (GOT) or glutamic pyruvic transaminase (GPT) in the subject. Also provided is a composition for treating hepatitis virus infection which comprises the yolk or yolk antibody in combination with one or more supplemental ingredients such as Salviae Miltiorrhiza Radix, Oldennlandiae Hb., Zingiberis Radix, Ginseng Radix, Atractylodis Radix, Curcumae Radix, Angelicae Sinensis Radix, bee propolis, calcium lactate, soy proteins, probiotics, and grain bran.

    Abstract translation: 本发明涉及一种治疗肝炎病毒感染的方法，包括向感染肝炎病毒的受试者施用有效量的从使用幽门螺杆菌作为抗原免疫的家禽卵获得的蛋黄或蛋黄抗体。 特别地，该方法在减少病人滴度和/或降低受试者中谷氨酰氧乙酰转氨酶（GOT）或谷氨酸丙酮酸转氨酶（GPT）的水平方面是有效的。 还提供了一种用于治疗肝炎病毒感染的组合物，其包含与一种或多种补充成分如丹参，老年人Hb。，姜科植物，人参，白术，白芍，当归中的蛋黄或蛋黄抗体 蜂胶，乳酸钙，大豆蛋白，益生菌和谷物麸皮。

    HERBAL COMPOSITIONS FOR THE INHIBITION OF HUMAN IMMUNODEFICIENCY VIRUS
    3.
    发明申请
    HERBAL COMPOSITIONS FOR THE INHIBITION OF HUMAN IMMUNODEFICIENCY VIRUS 审中-公开
    用于抑制人类免疫缺陷病毒的草本组合物

    公开(公告)号：US20080254148A1

    公开(公告)日：2008-10-16

    申请号：US11734926

    申请日：2007-04-13

    Applicant: Chih-Hui Lin

    Inventor： Chih-Hui Lin

    IPC: A61K36/536 ,  A61K36/748 ,  A61K36/86 ,  A61P31/18

    CPC classification number: A61K36/536 ,  A61K36/748 ,  A61K36/86

    Abstract: The invention provides a herbal composition for the inhibition of HIV, comprising an organic extract of Hedyotis diffusa (Oldenlandia diffusa), an organic solvent extract of Prunella vulgaris and an organic solvent extract of Viola philippica (Viola yedoensis).

    Abstract translation: 本发明提供了一种用于抑制HIV的草药组合物，其包含Hedyotis diffusa（Oldenlandia diffusa）的有机提取物，普通寻常果的有机溶剂提取物和Viola phedipensis（Viola yedoensis）的有机溶剂提取物。

    Morinda citrifolia enhanced colon cancer cell growth inhibitor
    4.
    发明申请
    Morinda citrifolia enhanced colon cancer cell growth inhibitor 审中-公开
    海巴戟天增强结肠癌细胞生长抑制剂

    公开(公告)号：US20060193932A1

    公开(公告)日：2006-08-31

    申请号：US11343600

    申请日：2006-01-31

    Applicant: Claude Jensen ,  Afa Palu ,  Stephen Story ,  Summer Jensen ,  Chen Su

    Inventor： Claude Jensen ,  Afa Palu ,  Stephen Story ,  Summer Jensen ,  Chen Su

    IPC: A61K36/748

    CPC classification number: A61K36/746

    Abstract: The present invention features methods and formulations or compositions for the treatment of colon cancer, and particularly for the inhibition, prevention and/or reduction of cancerous cell growth, as well as the destruction of early stage cancerous cells within the colon region of a mammal, wherein the formulations and compositions comprise an identified amount or concentration of a processed Morinda citrifolia product or an active ingredient there from, as obtained from the Indian Mulberry plant.

    Abstract translation: 本发明的特征在于用于治疗结肠癌的方法和制剂或组合物，特别是用于抑制，预防和/或减少癌细胞生长以及哺乳动物结肠区域中早期癌细胞的破坏， 其中所述制剂和组合物包含从印度桑树植物获得的已鉴定量或浓度的经加工的海巴戟天产品或其活性成分。

    Drinking tea for treating dermatitis
    5.
    发明申请
    Drinking tea for treating dermatitis 有权
    喝茶治疗皮炎

    公开(公告)号：US20050186293A1

    公开(公告)日：2005-08-25

    申请号：US10511024

    申请日：2002-04-15

    Applicant: Tetsuo Santo ,  Songhua Li ,  Ruwei Wang ,  Sumio Iwasaki

    Inventor： Tetsuo Santo ,  Songhua Li ,  Ruwei Wang ,  Sumio Iwasaki

    IPC: A23F3/34 ,  A23L1/30 ,  A23L1/38 ,  A61K9/08 ,  A61K36/185 ,  A61K36/232 ,  A61K36/287 ,  A61K36/30 ,  A61K36/315 ,  A61K36/484 ,  A61K36/489 ,  A61K36/505 ,  A61K36/534 ,  A61K36/539 ,  A61K36/704 ,  A61K36/748 ,  A61K36/752 ,  A61K36/90 ,  A61P17/00 ,  A61K35/78

    CPC classification number: A61K36/704 ,  A23F3/34 ,  A23L33/105 ,  A23V2002/00 ,  A61K36/185 ,  A61K36/232 ,  A61K36/287 ,  A61K36/30 ,  A61K36/315 ,  A61K36/484 ,  A61K36/489 ,  A61K36/505 ,  A61K36/534 ,  A61K36/539 ,  A61K36/748 ,  A61K36/752 ,  A61K36/90 ,  A61K2300/00 ,  A23V2250/214 ,  A23V2250/21

    Abstract: TECHNICAL FIELD: Tea TECHNICAL PROBLEM: To provide a drinkable tea having a high therapeutic effect against dermatitis. MEANS FOR SOLVING: It is characterized in that it contains extracts drawn from one, two or more medicinal herbs selected from the group consisting of Lightyellow Sophora Root, Isatis Leaf, and Terminalia Fruit. Atopic dermatitis can be cured by improving allergic constitution from the inside of body owing to antibacterial effect and antiviral effect of Lightyellow Sophora Root, Isatis Leaf and Terminalia Fruit, antiallergic effect of Lightyellow Sophora Root and Isatis Leaf, and intestinal mucosal protecting effect of Terminalia Fruit, or by a synergistic effect of them. In addition, the pharmocological effect in said extracts drawn from plants is enhanced, a pharmacological effects lacking in said extracts drawn from plants are added, or easiness of drinking the tea as a drinkable drug is imroved and thus the therapeutic effect is improved by adding one, two or more auxiliary materials selected from the group of Japanese Angelica Root, Oldenlandia diffusa, Smilax Glarba, Dried Tangerine Peel, Wild Chrysanthemum Flower, Corydalis, Peppermint, Baikal Skullcap, Lithospermum, Kudingcha, Smartweed, and Licorice to the extracts drawn from plants. Principal Use: It is used for the therapy of dermatitis, particularly of atopic dermatitis.

    Abstract translation: 技术领域：茶技术问题：提供对皮炎有较高疗效的饮用茶。 解决方法：其特征在于，其含有从一种，两种或更多种选自由淡黄色苦参，Is叶和终端果实组成的组中提取的提取物。 特应性皮炎可以通过改善身体内部的过敏症状，通过抗菌效果和Lightyellow Sophora Root，Isatis Leaf和Terminalia Fruit的抗病毒作用，Lightyellow Sophora Root和Isatis Leaf的抗过敏作用以及Terminalia Fruit的肠粘膜保护作用来治愈 ，或通过它们的协同效应。 此外，从植物提取的所述提取物中的药学作用增强，从植物中提取的所述提取物中缺乏药理作用，或者作为可饮用药物容易地喝茶，因此通过添加一种方法来改善治疗效果 ，从植物提取的提取物中选出的两种或更多种辅助材料，从日本当归根，古兰克氏菌，Sm ax，干橘皮，野菊花，延胡索，薄荷，贝加尔骷髅，紫草，葛根，仙妮草， 。 主要用途：用于治疗皮炎，特别是特应性皮炎。

Patent Agency Ranking